CNSide Diagnostics
Overview
CNSide Diagnostics is a genetic testing company specializing in central nervous system (CNS) disorders and neurological conditions through advanced diagnostic analysis. The company provides healthcare providers and patients with precise genetic insights to support diagnosis, treatment planning, and clinical decision-making for CNS-related genetic diseases.
More in Genetic Testing
Latest industry news
Roche Korea Recognized for Advancing Cancer Precision Medicine as Oncogenomics Gains Regional Momentum
2026-09-07 · Industry
Guardant Health Jumps 25% After FDA Clears First Genomic-Epigenomic Liquid Biopsy Panel
2026-09-06 · Product
Singapore's National Precision Medicine Program Charts a Path from Genomic Data to Clinical Practice
2026-09-05 · Research
BioNTech Veterans Secure $25M Seed Round to Build AI-Powered Cancer Surveillance Platform
2026-09-04 · Funding
Company details
Category
🧬 Genetic Testing
Funding
Private
Listed
2026-07-29
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →